Overall survival in mantle cell lymphoma up with deferred Tx
(HealthDay)—For patients with mantle cell lymphoma (MCL), deferred therapy seems safe and is an independent predictor of overall survival, according to a study published online May 6 in Cancer.
May 24, 2016
0
0